Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this extension study was to collect long-term safety and tolerability
information to support a marketing authorisation application for a three-month dosage regimen
of degarelix.